---
title: "Transportable AKI Prediction with an Explainable XGBoost Model Using MIMIC‑IV"
id: "medrxiv-2-toward-transportable-acute-kidney-injury-prediction-an-explainable-xgboost"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-toward-transportable-acute-kidney-injury-prediction-an-explainable-xgboost"
content_type: "clinical_feed_article"
specialty: "Nephrology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1?rss=1"
published_at: "2026-09-03T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Transportable AKI Prediction with an Explainable XGBoost Model Using MIMIC‑IV
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-toward-transportable-acute-kidney-injury-prediction-an-explainable-xgboost
- **Specialty:** [Nephrology](https://medichelpline.com/clinical-feed/nephrology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1?rss=1)
- **Published At:** 2026-09-03T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This study developed a 37-feature **XGBoost** model to predict **acute kidney injury (AKI)** using the MIMIC‑IV dataset, where AKI prevalence was 5.4% in the cohort. The model's hyperparameters were optimized with Optuna and output probabilities calibrated with isotonic regression. - Temporal, patient-level internal validation simulated prospective deployment by training on 2008–2016 admissions and testing on 2017–2022 admissions; the internal test AUROC for predicting AKI onset within a 12–24 hour window was 0.794 (95% CI 0.789–0.799). - External validation used the eICU Collaborative Research Database (multi-center, 208 US hospitals). The trained model was applied without retraining and achieved an AUROC of 0.750. - Explainability was provided with SHAP TreeExplainer to generate feature-level explanations for individual predictions. - The authors report equitable discrimination across subgroups defined by gender, age, chronic kidney disease status, race, and AKI stages on both datasets. - The study emphasizes transportability and clinical utility achieved with substantially fewer features than many prior models that require hundreds to thousands of inputs. - Data sources were MIMIC‑IV v3.1 and eICU CRD v2.0 accessed via PhysioNet under Data Use Agreements; code is available on request from the corresponding author. - Ethical approval was obtained from the Ethics Committee of the School of Computing, Miva Open University. The authors declared no competing interests.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=1A4PF7f5Z7ugm1074xkFffoI_1WIvymVZAGPAXuc998-1788493854.1577406-1.2.1.1-HLFfaYfcyuZwb8Nngwjw5aTvnVreJoh6B1ORQqIwvqUGWFaVhIM5I0HoFkIMXa.n) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Toward Transportable Acute Kidney Injury Prediction: An Explainable XGBoost Model with Temporal Validation Using MIMIC-IV [ View ORCID Profile](http://orcid.org/0009-0002-1447-455X)Daniel Osaseri Okundaye, [ View ORCID Profile](http://orcid.org/0009-0009-1197-8833)Chinyere Chioma Isiekwene doi: https://doi.org/10.64898/2026.09.01.26360393 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Daniel Osaseri Okundaye Miva Open University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Daniel%2BOsaseri%2BOkundaye%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Okundaye%20DO&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADaniel%2BOsaseri%2BOkundaye%2B) * [ORCID record for Daniel Osaseri Okundaye](http://orcid.org/0009-0002-1447-455X "Open in new tab") * For correspondence: daniel.okundaye@miva.edu.ng Chinyere Chioma Isiekwene Miva Open University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chinyere%2BChioma%2BIsiekwene%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Isiekwene%20CC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChinyere%2BChioma%2BIsiekwene%2B) * [ORCID record for Chinyere Chioma Isiekwene](http://orcid.org/0009-0009-1197-8833 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1292162/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1292162/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1292162/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1292162/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1292162/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Acute kidney injury (AKI) is a frequent complication within intensive care units, with its sudden onset often missed. This is especially important because a timely window for intervention is required as delayed detection leads to progressively worse outcomes. Existing machine learning and deep learning models have contributed to closing this gap, but their complexity, requiring hundreds to thousands of features, and lack of generalisation pose a limitation that prevents them from being integrated into clinical workflows across different electronic health-record ecosystems. This study presents a 37-feature XGBoost model trained on the MIMIC-IV dataset with 5.4% positive cases, with hyperparameters optimised via Optuna and probabilities calibrated using isotonic regression, designed for transportability across clinical settings. Validation was conducted internally using a temporal patient-level split simulating prospective deployment, training on 2008-2016 data and testing on 2017-2022 data"External validation was performed on the eICU Collaborative Research Database, a multi-centre dataset spanning 208 US hospitals, using the trained model without retraining. SHAP TreeExplainer was used to provide feature-level explainability for individual predictions. Internal testing yielded an AUROC score of 0.794 for predicting AKI onset within a 12-24 hour window. External validation produced a 0.750 AUROC without retraining. Equitable discrimination was observed across gender, age, chronic kidney disease presence, race, and AKI stages on both datasets, with a 95% internal CI of 0.789-0.799 confirming the model's estimate stability. These results suggest that clinically useful prediction systems are achievable with substantially fewer features than current models require. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Ethics Committee of the School of Computing, Miva Open University gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability This study utilized two publicly available de-identified datasets accessed through PhysioNet with signed Data Use Agreements: MIMIC-IV v3.1 and eICU Collaborative Research Database v2.0. Both require completion of CITI human subjects training and PhysioNet credentialing. Code is available upon request from the corresponding author. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.01.26361894v1 "Patterns of Post-Traumatic Stress Disorder and Associated Cognitive Factors Among Flood Victims in Hanang District, Tanzania")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.01.26361418v1 "Electronic health data exploring cardiorespiratory responses of transfusions in preterm infants: An international multicenter cohort study") Posted September 03, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/03/2026.09.01.26360393.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.01.26360393v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/03/2026.09.01.26360393.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Toward Transportable Acute Kidney Injury Prediction: An Explainable XGBoost Model with Temporal Validation Using MIMIC-IV Daniel Osaseri Okundaye, Chinyere Chioma Isiekwene medRxiv 2026.09.01.26360393; doi: https://doi.org/10.64898/2026.09.01.26360393 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26360393v1%26text%3DToward%2520Transportable%2520Acute%2520Kidney%2520Injury%2520Prediction%253A%2520An%2520Explainable%2520XGBoost%2520Model%2520with%2520Temporal%2520Validation%2520Using%2520MIMIC-IV "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26360393v1%26t%3DToward%2520Transportable%2520Acute%2520Kidney%2520Injury%2520Prediction%253A%2520An%2520Explainable%2520XGBoost%2520Model%2520with%2520Temporal%2520Validation%2520Using%2520MIMIC-IV "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26360393v1%26title%3DToward%2520Transportable%2520Acute%2520Kidney%2520Injury%2520Prediction%253A%2520An%2520Explainable%2520XGBoost%2520Model%2520with%2520Temporal%2520Validation%2520Using%2520MIMIC-IV%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26360393v1%26title%3DToward%2520Transportable%2520Acute%2520Kidney%2520Injury%2520Prediction%253A%2520An%2520Explainable%2520XGBoost%2520Model%2520with%2520Temporal%2520Validation%2520Using%2520MIMIC-IV "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.01.26360393) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.01.26360393v1&count=horizontal&via=&text=Toward%20Transportable%20Acute%20Kidney%20Injury%20Prediction%3A%20An%20Explainable%20XGBoost%20Model%20with%20Temporal%20Validation%20Using%20MIMIC-IV&counturl=www.medrxiv.org/content/10.64898/2026.09.01.26360393v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (615) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (896) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (327) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4774) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (475) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (408) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (644) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1615) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15843) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1196) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6990) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1058) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4993) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1428) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1740) * [Hematology](https://www.medrxiv.org/collection/hematology) (583) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1337) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16246) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1162) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (663) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (151) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (721) * [Neurology](https://www.medrxiv.org/collection/neurology) (7202) * [Nursing](https://www.medrxiv.org/collection/nursing) (365) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1074) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1233) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1001) * [Oncology](https://www.medrxiv.org/collection/oncology) (3577) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1038) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (393) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (448) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (466) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (704) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1777) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (733) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (759) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5838) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9703) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2389) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1436) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1244) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (635) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (769) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (577) * [Surgery](https://www.medrxiv.org/collection/surgery) (768) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (303) * [Urology](https://www.medrxiv.org/collection/urology) (286) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) ## Follow this preprint X You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the [medRxiv Alerts Page](https://medrxiv.org/ale
## Related Clinical Research

- [Long-term Renal Outcomes After Neonatal and Pediatric Renal Vein Thrombosis](https://medichelpline.com/clinical-feed/medrxiv-15-renal-outcomes-in-survivors-of-neonatal-and-pediatric-renal-vein-thrombosis.md)
- [Nintedanib-Linked Glomerular Endothelial Injury and Secondary Collapsing FSGS: SGLT2 Inhibitor as](https://medichelpline.com/clinical-feed/pubmed-42674550.md) (DOI: 10.1111/nep.70274)
- [Infection Does Not Impair Decongestion or Short-Term Kidney Outcomes in Cardiorenal Syndrome Type 1](https://medichelpline.com/clinical-feed/plos-one-11-impact-of-infection-on-decongestion-and-kidney-outcomes-in-patients-with.md)
- [Iron-related Parameters and Sepsis-associated Acute Kidney Injury — Source Content Not Available](https://medichelpline.com/clinical-feed/frontiers-in-immunology-19-association-of-iron-related-parameters-with-the-development-of-sepsis.md)
- [Disseminated melioidosis with symmetrical peripheral gangrene and multi-organ failure: case report](https://medichelpline.com/clinical-feed/frontiers-in-immunology-9-disseminated-melioidosis-complicated-by-symmetrical-peripheral-gangrene-and.md)

## Navigation
- [← Back to Nephrology Feed](https://medichelpline.com/clinical-feed/nephrology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.